GRAPPA 2007: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

Journal of Rheumatology

Volumn 35, Issue 7, 2008, Pages 1420-1422

  Gladman, Dafna D ^a,b,c  

^a GRAPPA ^*

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Psoriasis; Psoriatic arthritis

Indexed keywords

BIOLOGICAL MARKER; METHOTREXATE;

CLINICAL ASSESSMENT; CONFERENCE PAPER; DERMATOLOGY; DIAGNOSTIC IMAGING; DRUG INDUSTRY; DRUG USE; GENETICS; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; PATIENT SAFETY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY CONTROL; REGISTER; RHEUMATOLOGY; SCIENTIST; SCREENING TEST; UNITED STATES;

ARTHRITIS, PSORIATIC; BIOMEDICAL RESEARCH; HUMANS; PSORIASIS;

EID: 47349120226     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
2. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
3. Taylor WJ, Helliwell PS. Psoriatic arthritis is a joint-damaging disease - a call for action! Rheumatology Oxford 2007;46:1747-8.
4. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology Oxford 2003;42:1460-8.
5. Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56:2708-14.
6. Ciocon DH, Kimball AB. Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol 2007;157:850-60.
7. Mease PJ, Gladman DD, Krueger GG. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ann Rheum Dis 2005;64 Suppl II:ii1-2.
8. Helliwell PS. GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, Stockholm, May/June 2006. J Rheumatol 2007;34:214-9.
9. Gladman DD, Mease PJ, Krueger G, et al. Outcome measures in psoriatic arthritis. J Rheumatol 2005;32:2262-9.
10. Gladman DD, Mease PJ, Strand V, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70.
11. Gladman DD, Mease PJ. Towards international guidelines for the management of psoriatic arthritis. J Rheumatol 2006;33:1228-30.
12. Kavanaugh AF, Ritchlin CT. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 2006;33:1417-21.
13. Qureshi AA, Dominguez P, Duffin KC, et al. Psoriatic arthritis screening tools. J Rheumatol 2008;35:1423-5.
14. Mease PJ. Assessment tools in psoriatic arthritis. J Rheumatol 2008;35:1426-30.
15. Boehncke W-H, Adebajo A, Cauli A, Nash P, Salvarani C, Kavanaugh A. Initiative for quality in psoriasis and psoriatic arthritis. J Rheumatol 2008;35:1431-3.
16. Ritchlin CT. From skin to bone: translational perspectives on psoriatic disease. J Rheumatol 2008;35:1434-7.
17. de Vlam K, Gottlieb AB, FitzGerald O. Biological biomarkers in psoriatic disease. A review. J Rheumatol 2008;35:1443-8.
18. Coates LC, Anderson RR, FitzGerald O, et al. Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol 2008;35:1438-42.
19. Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 2008;35:1449-53.
20. Taylor WJ, Korendowych E, Nash P, et al. Drug use and toxicity in psoriatic disease: focus on methotrexate. J Rheumatol 2008;35:1454-7.
21. Gladman DD, Rahman P, Krueger GG, et al. Clinical and genetic registries in psoriatic disease. J Rheumatol 2008;35:1458-63.